Neuronetics Q2 Operating Expenses USD 22.7 Million
STIM•Q2 results
Aug. 11 (Reuters) - Neuronetics Q2 EPS USD -0.05.
-
Q2 gross margin 51.1%
-
Q2 operating expenses USD 22.7 million
Related News
AppLovin <APP.O>: Bofa Global Research cuts price objective to $400.00 from $430.00
APP•
Infinimmune Raises $75 Million Series A Financing To Advance Pipeline Of Human-Derived Antibodies For Atopic Dermatitis And Inflammatory Disease
REGN•
